Breakthrough bioanalysis
Alderley Analytical is an independent Contract Research Organisation (CRO). We offer specialist bioanalytical services to support your drug development programmes, from discovery through to late stage clinical development, focusing on small molecules, large molecules, peptides and biomarkers.
Enabling rapid drug development
Our biotech, pharma and CRO clients have discovered that keeping their bioanalysis with one provider means fewer laboratory transfers and no loss of bioanalytical knowledge of the molecule. By simplifying this process, it means fewer complications helping the rapid development of new drugs.
We take a flexible and responsive approach, using our collective expertise to develop novel bioanalytical methods and deliver your results on-time to the right quality. We also pride ourselves on excellent communication; you’ll find us easy to get hold of and we stay in touch, even if there’s no news to report.
As a GLP and GCP accredited laboratory, we can offer regulatory compliance where needed and are able to validate bioanalytical methods and deliver bioanalytical results to current FDA/EMA guidelines. Get in touch to discuss your bioanalysis requirements today.
Resources
Good luck to the Medusa-19 team!
Good luck to the Medusa-19 team as they continue to develop their Rapid Saliva Protein Test. Alderley Analytical are delighted to have been able to help them out a little on this exciting project. View the news report below -...
We are Recruiting
Alderley Analytical are looking for a Principal Bioanalytical Scientist to join the team. Due to the ongoing success of Alderley Analytical, we are looking for another Principal Scientist to join their Method Development Group to...
Alderley Analytical: COVID-19 and business continuity
We wanted to tell you about the measures that Alderley Analytical are implementing relating to the COVID-19 outbreak to ensure the business continues uninterrupted. As a company which is well prepared to manage modern teams and...
Our clients
